Prevalence of group B Streptococcus colonisation in mother–newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational study
Authors:
- Gaurav KwatraGKGaurav Kwatra
Open Access
- 20 August 2024
- journal article
- research article
- Published by Elsevier in The Lancet Microbe
- Vol. 5 (10) , 100897
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation (INV-008687)
This publication has 24 references indexed in Scilit:
- Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burdenThe Lancet Global Health, 2022
- Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development GoalsThe Lancet Child & Adolescent Health, 2022
- Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitionsVaccine, 2019
- Number of colony forming units in urine at 35–37 weeks’ gestation as predictor of the vaginal load of Group B Streptococci at birthEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2018
- Group B streptococcal colonization and transmission dynamics in pregnant women and their newborns in Nigeria: implications for prevention strategiesClinical Microbiology and Infection, 2017
- Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2016
- Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal KenyaNature Microbiology, 2016
- Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infantsVaccine, 2015
- Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant womenClinical Microbiology and Infection, 2015
- Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccineVaccine, 2013